Alexander Gelbard
Vanderbilt University Medical Center
Director North American Airway Collaborative
More
Haven't backed any projects yet!
Published on Jun 28, 2018
Your energy and drive for answers will keep us moving fast to cure iSGS.
478
-2
42
Published on Jun 20, 2018
Clarity in outcomes is critical to a cure.
323
-2
5
Published on Jun 16, 2018
Our recent experiments show high levels of the inflammatory cytokine IL-17A in iSGS airway scar. IL-17A also appears to drive cells within the airway lining to proliferate and create scar. We hope this finding will translate into better new treatmen...
Our recent experiments show high levels of the inflammatory cytokine IL-17A in iSGS airway scar. IL-17A also appears to drive cells within the airway lining to proliferate and create scar. We hope...
556
0
11
Published on Jun 16, 2018
NoAAC surgeons debate treatment options in iSGS
244
1
3
Published on Jun 12, 2018
The "iSGS 1000" created thru the North American Airway Collaborative's PCORI-funded study has exponentially accelerated the search for a cure. Large prospective cohorts (groups) of patients with a specific disease are critical to assess genetic and ...
The "iSGS 1000" created thru the North American Airway Collaborative's PCORI-funded study has exponentially accelerated the search for a cure. Large prospective cohorts (groups) of patients with a...
216
0
3
In a Gresham Lecture in London, Surgeon Dr. Martin Elliott discusses the critical role of reliable and transparent data in surgical innovation.
0 likes
Dr. Elliot discusses the importance of reliable and transparent outcomes surgical innovation
0 likes
Kat, you are exactly right the small blue circle is TGF-B (beta). There are FDA approved drugs that block IL-17A (cosentyx and Talz). While there are not trials currently open to test this in iSGS - NoAAC is working on getting this going - so stay tuned.
4 likes
